National Quality Measures Clearinghouse | Measures by Topic: Mental Disorders 4

National Quality Measures Clearinghouse | Measures by Topic

Measures by Topic

Disease/Condition > Psychiatry and Psychology (333) >

Mental Disorders (217)

Narrow:

Adjustment Disorders (1)
Anxiety Disorders (8)
Delirium, Dementia, Amnestic, Cognitive Disorders (9)

View all...

61-80 of 217   < Previous | Next >
61. Antidepressant medication management (effective acute phase treatment): percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication for at least 84 days (12 weeks). 2014 Sep. NQMC:009812 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
62. Antidepressant medication management (effective continuation phase treatment): percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication for at least 180 days (6 months).2014 Sep. NQMC:009813 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
63. Antipsychotic use in persons with dementia: percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition. 2014 Sep. NQMC:009260 Pharmacy Quality Alliance - Clinical Quality Collaboration. View all measures by the developer(s) Compare Selected
64. Cardiovascular monitoring for people with cardiovascular disease and schizophrenia: percentage of members 18 to 64 years of age with schizophrenia and cardiovascular disease who had an LDL-C test during the measurement year. 2014 Sep. NQMC:009820 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
65. Diabetes monitoring for people with diabetes and schizophrenia: percentage of members 18 to 64 years of age with schizophrenia and diabetes who had both an LDL-C test and an HbA1c test during the measurement year. 2014 Sep. NQMC:009819 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
66. Diabetes screening for people with schizophrenia or bipolar disorder who are using antipsychotic medications: percentage of members 18 to 64 years of age with schizophrenia or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year. 2014 Sep. NQMC:009818 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
67. Follow-up care for children prescribed ADHD medication (continuation and maintenance [C&M] phase): percentage of members 6 to 12 years of age with an ambulatory prescription dispensed for ADHD medication who remained on the medication for at least 210 days and who, in addition to the visit in the initiation phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended. 2014 Sep. NQMC:009815 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
68. Follow-up care for children prescribed ADHD medication (initiation phase): percentage of members 6 to 12 years of age with an ambulatory prescription dispensed for ADHD medication who had one follow-up visit with a practitioner with prescribing authority during the 30-day initiation phase. 2014 Sep. NQMC:009814 National Committee for Quality Assurance - Health Care Accreditation Organization. View all measures by thedeveloper(s) Compare Selected
69. Substance use: percent of discharged patients who received a diagnosis of alcohol or drug disorder during their inpatient stay, who are contacted between 7 and 30 days after hospital discharge and follow-up information regarding their alcohol or drug use status post discharge is collected. 2014 Apr. [NQMC Update Pending] NQMC:009558 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
70. Substance use: percent of hospitalized patients who are screened within the first three days of admission using a validated screening questionnaire for unhealthy alcohol use. 2014 Apr. [NQMC Update Pending]NQMC:009553 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
71. Substance use: percent of patients who are identified with alcohol or drug disorder who receive a prescription for FDA-approved medication for alcohol or drug use disorder or a referral for addictions treatment. 2014 Apr. [NQMC Update Pending] NQMC:009557 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
72. Substance use: percent of patients who are identified with alcohol or drug use disorder who received or refused at discharge a prescription for FDA-approved medication for alcohol or drug disorder or who received or refused a referral for addictions treatment. 2014 Apr. [NQMC Update Pending] NQMC:009556 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
73. Substance use: percent of patients who screened positive for unhealthy alcohol use who received or refused a brief intervention during the hospital stay. 2014 Apr. [NQMC Update Pending] NQMC:009554 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
74. Substance use: percent of patients who screened positive for unhealthy alcohol use who received the brief intervention during the hospital stay. 2014 Apr. [NQMC Update Pending] NQMC:009555 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
75. Tobacco treatment: percent of discharged patients who are identified through the screening process as having used tobacco products (cigarettes, smokeless tobacco, pipe, and cigars) within the past 30 days who are contacted between 15 and 30 days after hospital discharge and follow-up information regarding tobacco use status is collected. 2014 Apr. [NQMC Update Pending] NQMC:009552 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
76. Tobacco treatment: percent of hospitalized patients who are screened within the first three days of admission for tobacco use (cigarettes, smokeless tobacco, pipe and cigars) within the past 30 days. 2014 Apr. [NQMC Update Pending] NQMC:009547 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
77. Tobacco treatment: percent of patients identified as tobacco product users within the past 30 days who receive or refuse practical counseling to quit AND receive or refuse FDA-approved cessation medications during the first three days after admission. 2014 Apr. [NQMC Update Pending] NQMC:009548 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
78. Tobacco treatment: percent of patients identified as tobacco product users within the past 30 days who were referred to or refused evidence-based outpatient counseling AND received or refused a prescription for FDA-approved cessation medication upon discharge. 2014 Apr. [NQMC Update Pending] NQMC:009550 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
79. Tobacco treatment: percent of patients who received counseling AND medication as well as those who received counseling and had reason for not receiving the medication during the first three days after admission. 2014 Apr. [NQMC Update Pending] NQMC:009549 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
80. Tobacco treatment: percent of patients who were referred to evidence-based outpatient counseling AND received a prescription for FDA-approved cessation medication upon discharge as well as those who were referred to outpatient counseling and had reason for not receiving a prescription for medication. 2014 Apr.[NQMC Update Pending] NQMC:009551 The Joint Commission - Health Care Accreditation Organization. View all measures by the developer(s) Compare Selected
61-80 of 217   < Previous | Next >